Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:46 am Purchase |
2024-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
Adage Capital Management L.P. | 9,602,280 9.300% |
9,602,280 (New Position) |
Filing History |
| 2025-02-12 09:45 am Purchase |
2024-12-31 | 13G | Monopar Therapeutics Inc. MNPR |
Adage Capital Management L.P. | 599,195 9.860% |
599,195 (New Position) |
Filing History |
| 2025-02-12 09:44 am Sale |
2024-12-31 | 13G | Immunic, Inc. IMUX |
Adage Capital Management L.P. | 1,398,600 1.550% |
-4,195,806 (-75.00%) |
Filing History |
| 2025-02-12 09:36 am Purchase |
2024-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Adage Capital Management L.P. | 436,737 5.180% |
436,737 (New Position) |
Filing History |
| 2025-02-12 09:35 am Sale |
2024-12-31 | 13G | enGene Holdings Inc. Common Stock ENGN |
Adage Capital Management L.P. | 1,528,768 3.000% |
-801,000 (-34.38%) |
Filing History |
| 2025-02-12 09:35 am Sale |
2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Adage Capital Management L.P. | 2,209,615 6.680% |
-388,121 (-14.94%) |
Filing History |
| 2025-02-12 09:34 am Sale |
2024-12-31 | 13G | UroGen Pharma Ltd. URGN |
Adage Capital Management L.P. | 2,928,086 6.940% |
-807,655 (-21.62%) |
Filing History |
| 2025-02-12 09:33 am Purchase |
2024-12-31 | 13G | DYNAMIX CORP USD DYNX |
Adage Capital Management L.P. | 1,350,000 8.130% |
1,350,000 (New Position) |
Filing History |
| 2025-02-12 09:33 am Purchase |
2024-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
Adage Capital Management L.P. | 5,750,000 8.420% |
1,958,580 (+51.66%) |
Filing History |
| 2025-02-12 09:32 am Purchase |
2024-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Adage Capital Management L.P. | 325,000 9.380% |
106,187 (+48.53%) |
Filing History |
| 2025-02-12 09:32 am Purchase |
2024-12-31 | 13G | Zevra Therapeutics, Inc. ZVRA |
Adage Capital Management L.P. | 3,650,000 6.840% |
3,650,000 (New Position) |
Filing History |
| 2025-02-12 09:32 am Purchase |
2024-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Adage Capital Management L.P. | 3,000,000 5.560% |
3,000,000 (New Position) |
Filing History |
| 2025-02-12 09:31 am Purchase |
2024-12-31 | 13G | Seadrill Limited SDRL |
Adage Capital Management L.P. | 3,429,169 5.310% |
3,429,169 (New Position) |
Filing History |
| 2025-02-12 09:31 am Purchase |
2024-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Adage Capital Management L.P. | 9,627,304 9.000% |
9,627,304 (New Position) |
Filing History |
| 2025-02-12 09:31 am Purchase |
2024-12-31 | 13G | Sitio Royalties Corp. STR |
Adage Capital Management L.P. | 6,263,396 7.900% |
6,263,396 (New Position) |
Filing History |
| 2025-02-12 09:30 am Purchase |
2024-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Adage Capital Management L.P. | 2,250,000 6.560% |
2,250,000 (New Position) |
Filing History |
| 2025-02-12 09:30 am Purchase |
2024-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Adage Capital Management L.P. | 3,061,750 5.310% |
3,061,750 (New Position) |
Filing History |
| 2024-11-19 4:15 pm Purchase |
2024-06-30 | 13G | Zeo Energy Corp. ZEO |
Adage Capital Management L.P. | 760,000 5.950% |
760,000 (New Position) |
Filing History |
| 2024-11-12 09:40 am Purchase |
2024-09-30 | 13G | MeiraGTx Holdings plc MGTX |
Adage Capital Management L.P. | 5,229,099 6.770% |
5,229,099 (New Position) |
Filing History |
| 2024-11-12 09:38 am Purchase |
2024-09-30 | 13G | Annexon, Inc. ANNX |
Adage Capital Management L.P. | 3,485,931 3.280% |
3,485,931 (New Position) |
Filing History |